NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for flavopiridol


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from A. Ali and colleagues advance knowledge in HIV/AIDS
2009 NOV 1 ... anti-HIV-1 therapeutics," scientists in the United States report. "Flavopiridol, a small molecule CDK inhibitor, blocks HIV-1 Tat transactivation and viral replication ...
Subject: HIV/AIDS
Price: $3.00
*
Data on chronic lymphocytic leukemia published by researchers at Ohio State University
2009 MAY 4 ... results of a phase 1 trial in patients with chronic lymphocytic leukemia (CLL) whereby flavopiridol was administered intravenously as a 30-minute bolus followed by 4-hour infusion. We now ...
Subject: Chronic Lymphocytic Leukemia
Price: $3.00
*
Data on chronic lymphocytic leukemia therapy reported by researchers at Medical School
2009 NOV 9 ... lumiliximab, thalidomide and its analog lenalidomide, the semi-synthetic flavonoid flavopiridol and other agents which are currently undergoing clinical trials with promising ...
Subject: Chronic Lymphocytic Leukemia Therapy
Price: $3.00
*
Findings from T. Eguchi and co-authors provide new insights into cancer
2009 AUG 17 ... resulted in a transcriptional down-regulation of Mcl-1, a key molecule associated with flavopiridol-induced apoptosis, thereby leading to susceptibility to therapeutic intervention with ...
Subject: Cancer
Price: $3.00
*
Findings in breast cancer reported from Pfizer Inc.
2009 JUN 22 ... Mdr1a/1b(-/-), (-/-), Bcrp(-/-), and Mdr1a/1b(-/-), (-/-) Bcrp(-/-) mice. Four drugs, flavopiridol, imatinib mesylate (Gleevec), PF-407288, and prazosin, with different transport ...
Subject: Breast Cancer
Price: $3.00
*
New acute myeloid leukemia research has been reported by scientists at Sidney Kimmel Comprehensive Cancer Center
2009 AUG 31 ... have been developed and are being actively investigated in AML. Among these agents is flavopiridol, which interferes with key steps of the cell cycle and effectively promotes cell death, ...
Subject: Acute Myeloid Leukemia
Price: $3.00
*
New chronic lymphocytic leukemia therapy study findings have been reported by scientists at University of Ulm, Department of Internal Medicine III
2009 APR 20 ... treatment (alemtuzumab), immuno-modulating drugs (lenalidomide), CDK inhibitors (flavopiridol) and steroids." Zenz and colleagues published their study in Leukemia ...
Subject: Chronic Lymphocytic Leukemia Therapy
Price: $3.00
*
New life sciences research has been reported by scientists at Georgetown University, Medical Department
2009 JAN 5 ... and glial scarring," scientists in the United States report. "Flavopiridol-a cyclin-dependent kinase (CDK) inhibitor that is neither specific nor selective-is ...
Subject: Life Sciences
Price: $3.00
*
Research from Memorial Sloan Kettering Cancer Center, Department of Medicine in the area of cancer prevention published
2009 JUN 29 ... Research findings, 'A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer,' ...
Subject: Cancer Prevention
Price: $3.00
*
Research from University of Naples in DNA research provides new insights
2009 JUN 29 ... from DNA replication. Thus, CPT modulates P-TEFb equilibrium in a manner similar to Flavopiridol (FP), a pan-Cdk inhibitor proposed as chemotherapeutic agents against cancers. We ...
Subject: DNA Research
Price: $3.00
*
Research from University of Texas provide new insights into chronic lymphocytic leukemia
2009 JUN 29 ... the result of transcriptional inhibition rather than cleavage by caspase. Compared with flavopiridol and roscovitine, SNS-032 was more potent, both in inhibition of RNA synthesis and at ...
Subject: Chronic Lymphocytic Leukemia
Price: $3.00
*
Research in the area of myeloma reported from University of Texas
2009 APR 20 ... MET transcript and protein levels and this will lead to cell death. Pharmacological (flavopiridol) and molecular (shRNA) transcription inhibitor were used to impede formation of MET ...
Subject: Myeloma
Price: $3.00
*
Research on drug resistance published by scientists at St. John's University, Department of Pharmaceutical Sciences
2009 MAR 2 ... either wild-type or mutated ABCG2 to the ABCG2 substrate anti-cancer drugs flavopiridol and mitoxantrone. Neither AG1478 nor erlotinib sensitized ABCG2-overexpressing cells to ...
Subject: Drug Resistance
Price: $3.00
*
Scientists at University of California discuss research in cytomegalovirus
2009 JUL 13 ... of the IE2 protein at these sites. Infection in the presence of the cdk9 inhibitors Flavopiridol and DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) allowed cdk9 localization to ...
Subject: Cytomegalovirus
Price: $3.00
*
Studies from P. Bonvini and colleagues provide new data on large-cell lymphoma
2009 AUG 31 ... cells. In this study, we investigated the effect of the cdk inhibitor flavopiridol in anaplastic large cell lymphomas, in which unrestrained proliferation depends on ...
Subject: Large-Cell Lymphoma
Price: $3.00
*
Study data from University of Hamburg update knowledge of malaria
2009 SEP 21 ... interaction fields and also by a docking study of the known inhibitors kenpaullone and flavopiridol." Kruggel and colleagues published their study in QSAR & Combinatorial ...
Subject: Malaria
Price: $3.00
*
Study results from Ohio State University provide new insights into chronic lymphocytic leukemia
2009 NOV 9 ... apoptosis in CLL cells independent of p53 mutational status. The synthetic flavone flavopiridol demonstrated promising in vitro activity in CLL. In initial phase I studies using a ...
Subject: Chronic Lymphocytic Leukemia
Price: $3.00
*
Study results from University of Medicine and Dentistry of New Jersey update understanding of retinoblastoma
2009 APR 13 ... that control cell cycle progression, i.e., functional retinoblastoma protein (pRb). Flavopiridol inhibits proliferation and induces apoptosis in SCLC cell lines." ...
Subject: Retinoblastoma
Price: $3.00
*
Findings from INSERM broaden understanding of chronic lymphocytic leukemia therapy
2008 DEC 29 ... cells and downregulated during the apoptosis induced by other plant-derived molecules (flavopiridol, polyphenols, or hyperforin). This suggests different mechanisms of action for the ...
Subject: Chronic Lymphocytic Leukemia Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login